Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers. - Wikidata - awgldk - TriplyDB

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.

http://www.wikidata.org/entity/Q35749393

about

The CD44+/CD24- phenotype is enriched in basal-like breast tumors Loss of stromal caveolin-1 expression predicts poor clinical outcome in triple negative and basal-like breast cancers A machine learned classifier that uses gene expression data to accurately predict estrogen receptor status microRNA expression profiling identifies a four microRNA signature as a novel diagnostic and prognostic biomarker in triple negative breast cancers Subtyping of breast cancer by immunohistochemistry to investigate a relationship between subtype and short and long term survival: a collaborative analysis of data for 10,159 cases from 12 studies Long-term survival of women with basal-like ductal carcinoma in situ of the breast: a population-based cohort study Trp63 is regulated by STAT5 in mammary tissue and subject to differentiation in cancer.Basal keratin expression in breast cancer by quantification of mRNA and by immunohistochemistry.CD44 isoforms are heterogeneously expressed in breast cancer and correlate with tumor subtypes and cancer stem cell markers Prevalence of molecular subtypes and prognosis of invasive breast cancer in north-east of Morocco: retrospective study.Clinicopathlogic and immunohistochemical characteristics of triple negative invasive lobular carcinoma.Basal-like phenotype in a breast carcinoma case series from Sudan: prevalence and clinical/pathological correlations.A measure of the signal-to-noise ratio of microarray samples and studies using gene correlations Enhanced anticancer effect of the combination of cisplatin and TRAIL in triple-negative breast tumor cells The changing role of pathology in breast cancer diagnosis and treatment.Recent advances in cancer stem/progenitor cell research: therapeutic implications for overcoming resistance to the most aggressive cancers.Long non-coding RNA expression profiles predict metastasis in lymph node-negative breast cancer independently of traditional prognostic markers Triple-Negative Breast Cancer: Clinical and Histological Correlations.Triple negative breast cancer: unmet medical needs.Laminin 332 expression in breast carcinoma Basal breast cancer: a complex and deadly molecular subtype Demystifying basal-like breast carcinomas Overexpression of epithelial growth factor receptor (EGFR) predicts better response to neo-adjuvant chemotherapy in patients with triple-negative breast cancer Are triple-negative tumours and basal-like breast cancer synonymous?Basal cytokeratins in breast tumours among BRCA1, BRCA2 and mutation-negative breast cancer families An immune response gene expression module identifies a good prognosis subtype in estrogen receptor negative breast cancer.A robust classifier of high predictive value to identify good prognosis patients in ER-negative breast cancer.Patterns of Recurrence and outcome according to breast cancer subtypes in lymph node-negative disease: results from international breast cancer study group trials VIII and IX.The potential role of nanotechnology in therapeutic approaches for triple negative breast cancer.Does vimentin help to delineate the so-called 'basal type breast cancer'?Microarray-based gene expression profiling as a clinical tool for breast cancer management: are we there yet?Gene expression profiling integrated into network modelling reveals heterogeneity in the mechanisms of BRCA1 tumorigenesis A Comparison of Tumor Biology in Primary Ductal Carcinoma In Situ Recurring as Invasive Carcinoma versus a New In Situ.Beyond triple-negative breast cancer: the need to define new subtypes.Basal-like and triple-negative breast cancers: a critical review with an emphasis on the implications for pathologists and oncologists.Basal phenotype breast cancer: implications for treatment and prognosis.MUC1-mediated motility in breast cancer: a review highlighting the role of the MUC1/ICAM-1/Src signaling triad.Numb protein expression correlates with a basal-like phenotype and cancer stem cell markers in primary breast cancer.c-Met and ERβ expression differences in basal-like and non-basal-like triple-negative breast cancer.Immunohistochemical heterogeneity of breast carcinomas negative for estrogen receptors, progesterone receptors and Her2/neu (basal-like breast carcinomas).

P2860

Q21092906-CAA52A3D-5989-4D94-9829-5E67442D4157 Q24620397-F9D24A22-3037-4467-B31D-0B41E2A4FCAF Q30710027-C9473C67-5CC9-4A28-B710-B56CCB5C72F7 Q33576814-C86E1B04-BC1C-406A-82A8-12A08A90A498 Q33593016-40A1707E-C42E-4E23-A7E3-92244D0785CF Q33758934-7E9144B7-99B1-49FE-BCE3-026553D75307 Q33815791-A77EDFF7-6DB2-408D-A322-D48D5FBA4317 Q33864102-BFFEBFAF-C811-40E1-ADBE-F12036988AB5 Q34034939-64574AB6-90C9-4E80-BAA8-D5A4D95EAA28 Q34378272-5D9EB479-AC11-4F91-8B4F-01BA45394CC6 Q34474679-E2C6B82D-64C2-4C90-A79E-A420BC056EA5 Q34512811-AD99489B-C848-4F5A-91C3-4B676007C548 Q34516030-71B17FAE-5C2E-49FE-BC0F-206359A75BA9 Q34647893-85649591-62C6-4288-898D-7D303062AB52 Q35082260-52FCA418-B192-4B33-83D5-79D3F399B50C Q35459525-F2ED2861-EF5C-47C4-A01D-B882051202AC Q35559368-53506C39-377D-4108-91AD-3E234F81243C Q35576252-61E3C97B-3C47-425B-90CF-86B1D8380F25 Q35630269-970BB0D7-ADFE-44B9-94F2-2C4938C6295D Q35825928-F95F8DFA-4642-4865-A32B-AF896811AF6A Q35931900-0CE33A1A-7B84-47FB-9D4C-F8A5AB1E4E35 Q36172507-0D432F8C-BA6C-457F-8175-5AA14EAEE349 Q36244002-94D4BBCC-108B-4216-BA4C-D40AA2C2B271 Q36465310-069AD780-EBD8-465B-8C99-07B11B678D9E Q36643102-2DAF057B-0650-4BBC-BCCA-9965013F7672 Q36643153-066B9284-1663-4772-A314-F0FA107DDB2B Q36955150-BEB20E08-2C0A-4D1E-9A87-AB5579793B43 Q37122293-B670DDE3-24B0-43A1-8C31-321E9D0B3191 Q37304764-8BD0D9D3-D620-43F6-83FC-6606533E8BE8 Q37334872-3949F062-A5EC-48AB-8D1B-3DBD076ADA04 Q37356684-FDD87A1A-313C-4DAF-B55C-2860DDAB6E82 Q37401543-DA284E85-5525-47DA-9F43-24ADD41621C2 Q37486514-677C4681-797D-4A17-A486-D29C7D690E22 Q37782088-6DF84F6F-D934-4810-8155-EC3CDE44F84F Q37809456-076B2DA3-4A32-49A7-B23A-06CF35F9819D Q37853555-10688DF3-F240-4A35-8C9E-FD89B4C7E649 Q38373190-113815B2-A384-4689-B3F7-75EFE4E8AD2B Q39792989-46780D3E-570E-4878-9814-7766D60AB31A Q40858674-73BCD1F4-7C9A-45A2-99BC-9DBA9B50EEA1 Q42439372-2E4D0BA1-F7D2-4C9C-BEE3-B81CD9EBD236

P2860

Basal-like phenotype is not associated with patient survival in estrogen-receptor-negative breast cancers.

http://www.wikidata.org/entity/Q35749393

description

2007 nî lūn-bûn

@nan

2007年の論文

@ja

2007年論文

@yue

2007年論文

@zh-hant

2007年論文

@zh-hk

2007年論文

@zh-mo

2007年論文

@zh-tw

2007年论文

@wuu

2007年论文

@zh

2007年论文

@zh-cn

name

Basal-like phenotype is not as ...... eptor-negative breast cancers.

@ast

Basal-like phenotype is not as ...... eptor-negative breast cancers.

@en

type

label

Basal-like phenotype is not as ...... eptor-negative breast cancers.

@ast

Basal-like phenotype is not as ...... eptor-negative breast cancers.

@en

prefLabel

Basal-like phenotype is not as ...... eptor-negative breast cancers.

@ast

Basal-like phenotype is not as ...... eptor-negative breast cancers.

@en

P1433

Q35749393-B1E3FE80-C5B2-4345-AE16-A56CD9B750B4

P1476

Q35749393-3BFD8856-408D-40AC-A01D-42885B0E2E17

P2093

Q35749393-804458CD-6BF1-44CF-B5BB-086A72395070

Q35749393-84F5D299-0015-433C-868B-28DDE92CAA30

Q35749393-86F48B5A-BC47-4BE6-B866-FE61FB85883B

Q35749393-9B7275C3-9C79-42A5-8521-93F2B5C15B58

Q35749393-BE2A03D9-AA11-458D-BD77-9BF3F023BEDA

Q35749393-C927F528-824E-4088-9769-4E2FF19F33C7

Q35749393-CE619820-96A7-470B-9034-A8A9B35F37C4

Q35749393-E314E6B0-54C4-46DA-86DC-D1C1DA9A8AE9

Q35749393-E5AC87B1-D8A4-4043-AB22-9EA50CACB283

Q35749393-F034CE77-658E-4940-9715-2A18B29C9A5C

P2860

Q35749393-00E4E176-FEF3-448A-8C04-60E4FE4CED9C

Q35749393-088D4E91-0E72-41CC-86EE-5D0D7B4DC690

Q35749393-1EC38E7B-9726-4F54-8215-D9954457DB43

Q35749393-249178C2-058A-4975-BE03-D1BA07D4138D

Q35749393-25C1DA01-607D-4DE2-97A2-A876816B2E25

Q35749393-27E20419-0A96-49A1-934A-80A0C24D6578

Q35749393-2872B6DC-24BB-4B7F-B178-E4B13BA764C9

Q35749393-3AEC8976-1A83-42C8-BD36-FDED356519F6

Q35749393-3E9FC0A1-4844-41B8-9475-5407D0A73FDA

Q35749393-3F1A6F32-E946-4417-ACB3-0DA826B11468

P2888

Q35749393-FB879DEC-4CA7-4C7C-89B0-AD7B96D7304D

P304

Q35749393-F72B25F3-4993-43D7-8626-F80D534F76E2

P31

Q35749393-952B4F0D-64A7-4200-9E43-7030CDC1E18D

P356

Q35749393-62AA315D-E3AD-4ED5-9A79-807D404ACC4E

P433

Q35749393-8F8838A3-E625-40D6-B9FA-B3660E813482

P478

Q35749393-EC055171-FA6C-4248-BD5C-0F9D8CBF4412

P50

Q35749393-C6BC3906-46CB-4280-B4AE-CE2E1A5F86F3

P577

Q35749393-6BFD7C65-EC44-4DDA-A511-DB5BD232F575

P5875

Q35749393-CC9F0103-8EA8-404A-B094-4A597EB98BF3

P6179

Q35749393-F0BD0E01-EB5A-4160-A935-DC0FFAF95A3E

P698

Q35749393-1BD6A8A5-2DA1-4FC8-B2F3-E01FA110392D

P921

Q35749393-2A59F605-C4A1-4594-9A85-15FC3EA2AA54

P932

Q35749393-C9519934-84E5-4126-BE18-46F82500A5F0

P356

P1433

Breast Cancer Research

P1476

Basal-like phenotype is not as ...... ceptor-negative breast cancers

@en

P2093

Ake Borg

http://www.w3.org/2001/XMLSchema#string

Jorma Isola

http://www.w3.org/2001/XMLSchema#string

Mervi Jumppanen

http://www.w3.org/2001/XMLSchema#string

Mikael Lundin

http://www.w3.org/2001/XMLSchema#string

Minna Tanner

http://www.w3.org/2001/XMLSchema#string

Morten Krogh

http://www.w3.org/2001/XMLSchema#string

Mårten Fernö

http://www.w3.org/2001/XMLSchema#string

Pasi Kataja

http://www.w3.org/2001/XMLSchema#string

Päivikki Kauraniemi

http://www.w3.org/2001/XMLSchema#string

Pär-Ola Bendahl

http://www.w3.org/2001/XMLSchema#string

P2860

Cluster analysis and display of genome-wide expression patterns

Expression of cytokeratins 17 and 5 identifies a group of breast carcinomas with poor clinical outcome

BioArray Software Environment (BASE): a platform for comprehensive management and analysis of microarray data.

Expression profiling to predict outcome in breast cancer: the influence of sample selection

Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications

Gene expression profiling predicts clinical outcome of breast cancer

Normalization for cDNA microarray data: a robust composite method addressing single and multiple slide systematic variation.

Molecular classification of cancer: class discovery and class prediction by gene expression monitoring

Molecular portraits of human breast tumours

Repeated observation of breast tumor subtypes in independent gene expression data sets

P2888

P304

R16

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/BCR1649

http://www.w3.org/2001/XMLSchema#string

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

9

http://www.w3.org/2001/XMLSchema#string

P50

Sofia Gruvberger

P577

2007-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

6540440

http://www.w3.org/2001/XMLSchema#string

P6179

1012630585

http://www.w3.org/2001/XMLSchema#string

P698

17263897

http://www.w3.org/2001/XMLSchema#string

P921

P932

1851391

http://www.w3.org/2001/XMLSchema#string